Page last updated: 2024-11-02

pamidronate and Optic Neuritis

pamidronate has been researched along with Optic Neuritis in 1 studies

Optic Neuritis: Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect (Marcus-Gunn pupil), and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe (neuropapillitis or anterior optic neuritis) or the portion behind the globe (retrobulbar neuritis or posterior optic neuritis).

Research Excerpts

ExcerptRelevanceReference
"We describe the case of a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis."7.69Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria. ( Body, JJ; des Grottes, JM; Dumon, JC; Schrooyen, M, 1997)
"We describe the case of a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis."3.69Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria. ( Body, JJ; des Grottes, JM; Dumon, JC; Schrooyen, M, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
des Grottes, JM1
Schrooyen, M1
Dumon, JC1
Body, JJ1

Other Studies

1 other study available for pamidronate and Optic Neuritis

ArticleYear
Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria.
    Clinical rheumatology, 1997, Volume: 16, Issue:1

    Topics: Anti-Inflammatory Agents; Diphosphonates; Evoked Potentials, Visual; Female; Humans; Infusions, Intr

1997